Clinical course and mortality risk of severe COVID-19

The Lancet

Volumn 395, Issue 10229, 2020, Pages 1014-1015

  Weiss, Paul ^a   Murdoch, David R ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; COMORBIDITY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MORTALITY RATE; MORTALITY RISK; NOTE; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; THROAT CULTURE; VIRUS SHEDDING;

EID: 85082184759     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)30633-4     Document Type: Note

References (12)

1. Wu, Z, McGoogan, JM, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020 published online Feb 24. DOI:10.1001/jama.2020.2648.
2. Zhou, F, Yu, T, Du, R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020 published online March 9. https://doi.org/10.1016/S0140-6736(20)30566-3.
3. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
4. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
5. Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 2020 published online Feb 7. DOI:10.1001/jama.2020.1585.
6. Ahnert, P, Creutz, P, Horn, K, et al. Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia—results from the prospective observational PROGRESS study. Crit Care, 23, 2019, 110.
7. Snijders, D, Schoorl, M, Schoorl, M, Bartels, PC, van der Werf, TS, Boersma, WG, D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med 23 (2012), 436–441.
8. Guan, W-J, Ni, Z-Y, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020 published online Feb 28. DOI:10.1056/NEJMoa2002032.
9. Yang, X, Yu, Y, Xu, J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, 2020 published online Feb 24. https://doi.org/10.1016/S2213-600(20)30079-5.
10. Cheng, PKC, Wong, DA, Tong, LKL, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363 (2004), 1699–1700.
11. Corman, VM, Albarrak, AM, Omrani, AS, et al. Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection. Clin Infect Dis 62 (2016), 477–483.
12. Oh, M-D, Park, WB, Choe, PG, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 375 (2016), 1303–1305.